QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Groundbreaking Cancer Treatment on RedChip’s Bloomberg TV Program
Calidi Biotherapeutics (NYSE American: CLDI), a leader in oncolytic virotherapy (OV) for cancer, will feature in a RedChip Small Stocks, Big Money™ interview on Bloomberg TV on Oct. 26 at 7 p.m. ET. During the interview, Calidi’s Chief Business Officer, Stephen Thesing, provides an update on Calidi’s innovative approach, which uses engineered viruses to target and eliminate cancer cells. Calidi’s proprietary cell-based technology enhances the potency and longevity of these viruses by protecting them from immune response, boosting treatment efficacy. With IV-based and direct tumor administration methods, Calidi is advancing a new frontier in cancer treatment within the multi-billion-dollar oncology…
